4.6 Article

Synthesis, Biological Evaluation and Machine Learning Prediction Model for Fluorinated Cinchona Alkaloid-Based Derivatives as Cholinesterase Inhibitors

Related references

Note: Only part of the references are listed.
Review Clinical Neurology

Reimagining cholinergic therapy for Alzheimer's disease

Ezio Giacobini et al.

Summary: The review discusses the use of cholinesterase inhibitors in the treatment of Alzheimer's disease, the role of the basal forebrain cholinergic system in cognition, and potential future therapies targeting the NGF metabolic pathway and M1 muscarinic receptor. It provides an updated view of the cholinergic-oriented therapy of Alzheimer's disease and suggests new alternatives to enhance its clinical effect.

BRAIN (2022)

Article Plant Sciences

Synthesis of novel 9R/S-acyloxy derivatives of cinchonidine and cinchonine as insecticidal agents

Zhi-Ping Che et al.

Summary: A free 9-hydroxyl group is not necessary for insecticidal activity; C9-substitution is well tolerated; the configuration of the C8/9 position is crucial for insecticidal activity, with 9S-configuration being optimal.

JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH (2021)

Article Cell Biology

Cinchonine inhibits osteoclast differentiation by regulating TAK1 and AKT, and promotes osteogenesis

You-Jin Jo et al.

Summary: Studies have shown that Cinchonine inhibits osteoclast differentiation by regulating TAK1 to suppress NFATc1 and PGC1 beta, leading to the suppression of osteoclast differentiation and promotion of osteoblast differentiation. Furthermore, Cinchonine exhibits potential therapeutic effects in mouse models of inflammation-induced bone diseases and postmenopausal osteoporosis.

JOURNAL OF CELLULAR PHYSIOLOGY (2021)

Article Pharmacology & Pharmacy

Quinuclidine-Based Carbamates as Potential CNS Active Compounds

Ana Matosevic et al.

Summary: The study confirmed that quinuclidinium carbamates are promising candidates for further development as CNS-active drugs, particularly for Alzheimer's disease treatment. The synthesized compounds showed good acetylcholinesterase and butyrylcholinesterase inhibitory activity, and were able to pass the blood-brain barrier.

PHARMACEUTICS (2021)

Review Pharmacology & Pharmacy

Applications of fluorine to the construction of bioisosteric elements for the purposes of novel drug discovery

Paul Richardson

Summary: This review discusses the strategic use of fluorine substitution in the design and development of bioisosteres in medicinal chemistry, as well as the classic exploitation of trifluoroethylamine group as an amide bioisostere. It highlights the context-dependent influence of the fluorinated fragment on the overall properties of the compound in each case study presented.

EXPERT OPINION ON DRUG DISCOVERY (2021)

Article Clinical Neurology

2021 Alzheimer's disease facts and figures

[Anonymous]

Summary: Alzheimer's disease has a significant impact on individuals and society as a whole, with a large number of patients in the United States and a potential for continued growth in the future. The value of unpaid caregivers has increased despite a decline in their numbers, and healthcare costs are on the rise. Racial and ethnic disparities in healthcare persist, highlighting the need for greater diversity in dementia care workforce and clinical trials.

ALZHEIMERS & DEMENTIA (2021)

Article Chemistry, Medicinal

A Cinchona Alkaloid Antibiotic That Appears To Target ATP Synthase in Streptococcus pneumoniae

Xu Wang et al.

JOURNAL OF MEDICINAL CHEMISTRY (2019)

Article Clinical Neurology

2019 Alzheimer's disease facts and figures

Joseph Gaugler et al.

ALZHEIMERS & DEMENTIA (2019)

Article Chemistry, Medicinal

Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design

Nicholas A. Meanwell

JOURNAL OF MEDICINAL CHEMISTRY (2018)

Article Chemistry, Multidisciplinary

Discovery of Novel Cinchona-Alkaloid-Inspired Oxazatwistane Autophagy Inhibitors

Luca Laraia et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)

Article Chemistry, Multidisciplinary

Catalytic enantioselective epoxidation of nitroalkenes

A. Vidal-Albalat et al.

CHEMICAL COMMUNICATIONS (2016)

Article Biochemistry & Molecular Biology

AChE and the amyloid precursor protein (APP) - Cross-talk in Alzheimer's disease

Natalia N. Nalivaeva et al.

CHEMICO-BIOLOGICAL INTERACTIONS (2016)

Article Chemistry, Organic

Development of a Phase-Transfer-Catalyzed, [2,3]-Wittig Rearrangement

Scott E. Denmark et al.

JOURNAL OF ORGANIC CHEMISTRY (2015)

Article Chemistry, Multidisciplinary

Mechanochemical and Conformational Study of N-heterocyclic Carbonyl-Oxime Transformations

Ines Primozic et al.

CROATICA CHEMICA ACTA (2014)

Review Behavioral Sciences

The history of the cholinergic hypothesis

Antonio Contestabile

BEHAVIOURAL BRAIN RESEARCH (2011)

Article Chemistry, Analytical

In-line reaction monitoring of entacapone synthesis by Raman spectroscopy and multivariate analysis

Predrag Novak et al.

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2011)

Article Chemistry, Organic

Asymmetric Direct α-Hydroxylation of β-Oxo Esters by Phase-Transfer Catalysis Using Chiral Quaternary Ammonium Salts

Mingming Lian et al.

EUROPEAN JOURNAL OF ORGANIC CHEMISTRY (2010)

Article Multidisciplinary Sciences

Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer β-amyloid peptide in rodent

NH Greig et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Article Chemistry, Medicinal

Molecular properties that influence the oral bioavailability of drug candidates

DF Veber et al.

JOURNAL OF MEDICINAL CHEMISTRY (2002)

Review Pharmacology & Pharmacy

Prediction of intestinal permeability

WJ Egan et al.

ADVANCED DRUG DELIVERY REVIEWS (2002)

Article Chemistry, Inorganic & Nuclear

Asymmetric synthesis of N-aryl aziridines

J Aires-de-Sousa et al.

TETRAHEDRON-ASYMMETRY (2002)

Article Psychology, Clinical

Butyrylcholinesterase: An important new target in Alzheimer's disease therapy

NH Greig et al.

INTERNATIONAL PSYCHOGERIATRICS (2002)